KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2017-05-31
Total Revenue
9,392
9,582
891.677
-
0
Cost of Revenue
6,932
7,147
594.313
-
-
Gross Profit
2,460
2,436
297.364
-
-
Operating Expenses
Research Development
3,578
3,733
-
-
-
Selling General and Administrative
37,319
35,913
20,194
-
44.683
Total Operating Expenses
41,418
40,016
20,194
-
44.683
Operating Income or Loss
-38,958
-37,580
-19,896
-
-44.683
Total Other Income/Expenses Net
1,367
1,225
168.376
-
-
Income Before Tax
-37,590
-36,355
-19,728
-
-44.683
Income Tax Expense
21.043
22.746
78.58
-
-
Income from Continuing Operations
-37,611
-36,378
-19,807
-
-44.683
Net Income
-37,611
-36,378
-19,807
-
-44.683
Net Income available to common shareholders
-37,611
-36,378
-19,528
-
-44.683
Basic EPS
-
-0.36
-0.42
-0.14
-0.24
Diluted EPS
-
-0.36
-0.42
-0.14
-0.24
Basic Average Shares
-
101,966
48,519
27,757
189.583
Diluted Average Shares
-
101,966
48,519
27,757
189.583
EBITDA
-
-36,641
-19,558
-
-44.683